Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional, Prospective, Randomized, Multi-Center, Assessor-Blinded Study Designed to Assess the Safety and Effectiveness of the enVast Coronary Thrombectomy System as an Adjunctive Measure to Conventional Intervention in Subjects Presenting With ST-segment Elevation Myocardial Infarction (STEMI)

NCT04969471 is registered in ClinicalTrials.gov with Vesalio as lead sponsor.

NCT NCT04969471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04969471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional, Prospective, Randomized, Multi-Center, Assessor-Blinded Study Designed to Assess the Safety and Effectiveness of the enVast Coronary Thrombectomy System as an Adjunctive Measure to Conventional Intervention in Subjects Presenting With ST-segment Elevation Myocardial Infarction (STEMI)
Lead sponsor
Vesalio
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 9, 2021
Completion date
August 1, 2027
Enrollment
148 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

segment elevation myocardial infarction (stemi)